Soigner Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.70 M
as on 13-12-2024
- Company Age 8 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 13-12-2024
- Revenue 32.31%
(FY 2020)
- Profit 659.73%
(FY 2020)
- Ebitda 236.80%
(FY 2020)
- Net Worth 4.16%
(FY 2020)
- Total Assets 32.76%
(FY 2020)
About Soigner Medicament
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.00 M.
Harshit Mishra and Rajneesh Mishra serve as directors at the Company.
- CIN/LLPIN
U51909UP2017PTC089170
- Company No.
089170
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Soigner Medicament?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajneesh Mishra  | Managing Director | 26-Dec-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harshit Mishra | Director | 16-Jan-2017 | Current |
Financial Performance of Soigner Medicament.
Soigner Medicament Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 32.31% increase. The company also saw a substantial improvement in profitability, with a 659.73% increase in profit. The company's net worth moved up by a moderate rise of 4.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soigner Medicament?
Unlock access to Soigner Medicament's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2024 | Canara Bank | ₹1.00 M | Open |
How Many Employees Work at Soigner Medicament?
Unlock and access historical data on people associated with Soigner Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soigner Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soigner Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
